CLINICAL_TRIALS
research
· 2026-01-20
Clinical Trial Update: The Role of Microbiome in Recurrent Obesity Before and After Antibiotic/Placebo Treatment [NA]
Summary
A clinical trial from the Weizmann Institute of Science is investigating the role of the gut microbiome in recurrent obesity and how antibiotic treatment versus…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Weizmann Institute of Science | Conditions: Obesity, Weight Loss | NA | Status: RECRUITING